Compugen   Report issue

For profit Phase 1 Phase 2
Founded: Tel Aviv Israel (1993)

Organization Overview

First Clinical Trial
2018
NCT03667716
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Compugen Ltd | Compugen USA, Inc.